solution by MARKET
Pharmaceutical Production Lines & Turnkey Factory Solutions for Brazil
From IV solution filling lines and OSD plants to injectable systems, biologics equipment, and cleanroom engineering — GMP-compliant manufacturing infrastructure built for Latin America’s largest and most dynamic pharmaceutical market.
A Clear View of the Local Market Landscape
Brazil’s pharmaceuticals market was valued at USD 38.08 billion in 2024 and is projected to grow from USD 40.96 billion in 2025 to USD 73.79 billion by 2032, at a CAGR of 8.77%. Brazil is the largest and highest-value pharmaceutical market in Latin America, with a major focus on generic drugs due to their affordability. The Brazilian government is actively promoting local production of pharmaceuticals to reduce dependency on imports, with initiatives such as tax incentives and funding for local manufacturers — yet local production accounts for approximately 60% of the pharmaceutical market, leaving significant room for manufacturing capacity expansion. Policies aimed at strengthening domestic manufacturing capabilities, particularly for vaccines and essential medicines, are further reinforcing the resilience of Brazil’s pharmaceutical ecosystem.
Demand Trends Within the Country
-
•Generic Drug Manufacturing Expansion
Generic drugs are becoming increasingly popular due to their affordability and accessibility, with the Brazilian government implementing policies to promote generics, which now account for approximately 40% of the total pharmaceutical market. This drives demand for high-volume OSD and injectable production lines. -
Biologics & Biosimilars Production
ANVISA biosimilar approvals are accelerating, reinforcing the leading position of biologics and biosimilars in the Brazilian market, creating opportunities for bioreactor, fill-finish, and lyophilization equipment investments. -
Injectable & IV Solution Capacity
With SUS (Brazil’s universal health system) covering over 200 million people and the government responsible for 25–30% of pharmaceutical purchasing, demand for locally manufactured IV fluids, injectable antibiotics, vaccines, and parenteral nutrition far exceeds current domestic capacity. -
Oral Solid Dosage Dominance
Oral solid dosage forms dominate South America’s pharma contract manufacturing market, generating about 55% of total revenue, making tablet and capsule line investments the highest-priority segment for Brazilian manufacturers.
Local Experience, Reliable Execution
-
Proven Latin America delivery track record — 2,500+ production lines deployed in 60+ countries, with extensive project experience across South American and LATAM pharmaceutical markets.
-
ANVISA & international GMP alignment — All systems pre-engineered to meet EU GMP, US FDA cGMP, WHO GMP, and PIC/S GMP standards. Brazil’s ANVISA joined the Pharmaceutical Inspection Co-operation Scheme (PIC/S) in 2020, introducing new processes that allow product owners to launch products with greater ease — and our systems are built for full PIC/S compliance.
-
Full turnkey EPC capability — From consulting and process design through equipment manufacturing, cleanroom construction, utility installation, IQ/OQ/PQ validation, technology transfer, and operator training — one partner, one contract.
-
Customized for Brazil’s priorities — Solutions tailored for high-demand therapeutic areas (cardiovascular, oncology, diabetes, CNS, respiratory) and configured for ANVISA BGMP inspection requirements and SUS procurement eligibility.
Selected Products for This Market
-
Automated Warehouse System
Introduction The AS/RS system usually contains several parts as Rack system, WMS software, WCS operation level part and etc. It is widely adopted in many pharmaceutical and food production field. Product Video Photo of the System Description of the System The AS/RS system usually contains several parts as Rack system, WMS software, WCS operation level… -
Herb Extraction Production Line
Herb Extraction Production Line Introduction: Series of plant herb extraction system including Static/dynamic extraction tank system, filtration equipment, circulating pump, operating pump, operating platform, extraction liquid storage tank, pipe fittings and valves, vacuum concentration system, concentrated liquid storage tank, alcohol precipitation tank, alcohol recovery tower, configuration system, drying system. Natural flavors and fragrances: tobacco leaves,…
Meeting Local Standards with Reliable Delivery
Compliance & Certification
Logistics & Delivery
Success Snapshot
-
Generic Pharmaceutical Manufacturer
Delivered an integrated OSD production plant including tablet and capsule lines, purified water system, cleanroom, and blister packaging. The facility passed ANVISA BGMP inspection on first audit and achieved annual output of 800 million tablets and 200 million capsules, enabling the client to supply SUS-listed essential generics and export to three MERCOSUR countries.
-
Pharmaceutical Company
Supplied a vial filling line with lyophilization system, WFI system, Grade A/B cleanroom, and automated packaging for injectable biologics and biosimilar production. The project was completed in 16 months, achieving ANVISA GMP certification and enabling fill-finish capacity of 20 million vials annually for oncology and diabetes therapies.
Trusted by Local Customers
-
“IVEN delivered our complete OSD factory — equipment, cleanroom, water system, and packaging — as a single turnkey project. Their understanding of ANVISA BGMP requirements saved us months on the approval process. We were supplying SUS within 15 months of contract
Mr. C
Industrial Director
-
“Their vial filling and lyophilization solution was exactly what we needed for our biosimilar production. The technology transfer and operator training were thorough — our Brazilian team was fully independent within weeks of commissioning.”
Dr. P
VP of Operations
